Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
about
Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeatsElevated midbrain serotonin transporter availability in mixed mania: a case reportN-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataSubcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.Molecular, Functional, and Structural Imaging of Major Depressive Disorder.Dopamine transporters govern diurnal variation in extracellular dopamine tone.Modulation of visceral nociception, inflammation and gastric mucosal injury by cinnarizine.Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sampleIncongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAMGenetically determined dopamine availability predicts disposition for depression.Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats.Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112Greater striatal dopamine transporter density may be associated with major depressive episode.Depression, stress, and anhedonia: toward a synthesis and integrated model.Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.Incongruent reduction of dopamine transporter availability in different subgroups of alcohol dependence.Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention.Quantum dot approaches for target-based drug screening and multiplexed active biosensing.Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD.Bupropion interferes with the image diagnosis of Parkinson's disease.Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction.Altered affinity of the platelet vesicular monoamine transporter 2 to dihydrotetrabenazine in children with major depression.Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
P2860
Q24338948-3882D42C-6266-4157-B741-9E618D16634EQ24797109-305CC404-FCB5-40D2-9FCB-B95806B33211Q30000089-D06A46D1-7D71-4679-884C-7481EE5F45C4Q30440091-5F1EF9D4-44BD-4E94-A1B6-9370D071106EQ31090058-FDD7A390-E6B7-4E38-976E-48459BF47021Q33853949-DD58869B-8A63-4E86-A58F-D7837B4D5673Q35161769-71B2A441-8E7C-4611-9F83-B7DE5B94FCC4Q35165378-0BF88747-3840-4A2F-81C2-6C887155AD5BQ35179035-CBDB3DA8-ACF8-4646-BEC2-BF77BC7EFC6FQ35609346-C06CA2AD-A924-4F81-92AB-7C68CBF61791Q35864182-8EB8DD7D-C24B-4F40-A977-0B7557DED6ACQ37130593-C67E009A-F78F-43B5-94F8-8162075D16EEQ37353541-86382075-0EDE-489C-8583-7FBBC89A6374Q37678648-D7BFEE71-DE99-4756-BA7C-E940CFC6C28CQ37696215-AD687C82-D2DA-42F5-8E32-8C2BBB924DDEQ37726626-8450C888-CE20-4118-A296-B178FC7E3811Q37973223-7EB69A0D-5A20-4188-8271-572EA9413F54Q38129020-FB17AD0F-C75A-4903-BE22-F2292C98145AQ41542164-EE63EEE4-91DB-4FF9-BF4C-F34267837134Q41649807-C13500DA-8FA9-43D7-8DE0-12A126F4FCA1Q43101572-6FED7A81-D299-4966-A175-F226EF8320D4Q47139632-DB5C9B71-1554-474F-B0D2-8B4A112BFE63Q47981680-201C9B7C-8F69-4E6C-B596-87C37E1834EDQ48176784-2DF9AE36-6E68-4DF1-B492-9B6C10A1BEBDQ48377450-AFD65307-B465-44AC-91F4-159A9F608974Q48593238-31BFD3A0-33B1-4BB3-88F4-BBBC24626A18Q51804437-0A407F47-DF01-4C02-9C29-81A7DF55ED52Q59292055-045DDB03-B90D-4180-ADA1-933C08124DDC
P2860
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@en
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@nl
type
label
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@en
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@nl
prefLabel
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@en
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@nl
P2093
P1476
Greater availability of brain ...... 99m Tc]TRODAT-1 SPECT imaging.
@en
P2093
David J Brunswick
Jay D Amsterdam
P David Mozley
P304
P356
10.1176/APPI.AJP.160.10.1836
P407
P577
2003-10-01T00:00:00Z